Hypertension frequently results in severe complications in cardiovascular system and histopathological changes in the heart. To better understand the cellular processes and signaling pathways responsible for the proper functioning of the heart, we decided to check whether doxazosin affects the density of structures containing S100A6 and atrial natriuretic factor in the heart of spontaneously hypertensive rats. The aim of this study is to find differences in the density of the structures containing S100A6 and atrial natriuretic factor in the heart of spontaneously hypertensive rats treated with doxazosin compared to untreated animals. Fragments of heart were collected from five spontaneously hypertensive rats and five spontaneously hypertensive rats receiving doxazosin for six weeks (dose 0.1 mg per 1 kg of body weight). On the paraffin sections S100A6 and atrial natriuretic factor peptides were localized in the heart using immunohistochemistry. Positive immunohistochemical reaction for S100A6 was observed in atrial and ventricular cardiomyocytes and in the coronary vasculature. In the heart of hypertensive rats treated with doxazosin the S100A6 immunoreactivity was significantly lower compared to untreated animals. Immunodetection of atrial natriuretic factor in the heart of rats confirmed presence of peptide in atrial myocardium. Delicate atrial natriuretic factor-immunoreactivity was observed also in few ventricular cardiomyocytes. The atrial natriuretic factor-immunosignal was significantly weaker in hearts of hypertensive rats receiving doxazosin compared to spontaneously hypertensive rats untreated. Since we found that doxazosin reduces the levels of S100A6 and atrial natriuretic factor peptides in the heart of spontaneously hypertensive rats, it can be assumed that cardiovascular disorders that occur in hypertension may be associated with disturbances of cellular processes and signaling pathways.
SchmiederRE. End organ damage in hypertension. Dtsch Arztebl Int2010; 107: 866–73.
3.
NicolettiAHeudesDMandetCHinglaisNBarietyJMichelJB. Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc Res1996; 32: 1096–107.
4.
NarayananAAurigemmaGPChinaliMHillJCMeyerTETigheDA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging2009; 2: 382–90.
5.
DelbridgeLMConnellPJMorganTOHarrisPJ. Contractile function of cardiomyocytes from the spontaneously hypertensive rat. J Mol Cell Cardiol1999; 28: 723–33.
6.
LiZBingOHLongXRobinsonKGLakattaEG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol1997; 272: 2313–9.
7.
DonatoR. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta1999; 1450: 191–231.
8.
KrausCRohdeDWeidenhammerCQiuGPlegerSTVoelkersMBoerriesMRemppisAKatusHAMostP. S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy. J Mol Cell Cardiol2009; 47: 445–55.
9.
MacoBMandinovaADürrenbergerMBSchäferBWUhríkBHeizmannCW. Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart. Physiol Res2001; 50: 567–74.
10.
KettlewellSMostPCurrieSKochWJSmithGL. S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol2005; 39: 900–10.
11.
MostPBernotatJEhlermannPPlegerSTReppelMBörriesMNiroomandFPieskeBJanssenPMEschenhagenTKarczewskiPSmithGLKochWJKatusHARemppisA. S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci USA2001; 98: 13889–94.
12.
RemppisAMostPLöfflerEEhlermannPBernotatJPlegerSBörriesMReppelMFischerJKochWJSmithGKatusHA. The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes. Basic Res Cardiol2002; 97: 56–62.
13.
DesjardinsJFPourdjabbarAQuanALeong-PoiHTeichert-KuliszewskaKVermaSParkerTG. Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction. Am J Physiol Heart Circ Physiol2009; 296: 1457–65.
14.
PlegerSTHarrisDMShanCVingeLEChuprunJKBerzinsBPlegerWDruckmanCVölkersMHeierhorstJØieERemppisAKatusHAScaliaREckhartADKochWJMostP. Endothelial S100A1 modulates vascular function via nitric oxide. Circ Res2008; 102: 786–94.
15.
AuKWKouCYWooAYChimSSFungKPChengCHWayeMMTsuiSK. Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes. J Cell Biochem2006; 98: 555–66.
TsoporisJNIzharSParkerTG. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha. J Biol Chem2008; 283: 30174–83.
18.
TsoporisJTIzharSDesjardinsJFLeong-PoiHParkerTG. Conditional cardiac overexpression of S100A6 attenuates myocyte hypertrophy and apoptosis following myocardial infarction. Curr Pharm Des2014; 20: 1941–9.
19.
LarochellePCussonJRGutkowskaJSchiffrinELHametPKuchelOGenestJCantinM. Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. Br Med J (Clin Res Ed)1987; 294: 1249–52.
20.
AnMRChungYJKangDGNamSCLeeJ. Augmented expression of cardiac atrial natriuretic peptide system in hypertensive rats. J Korean Med Sci1999; 14: 497–501.
21.
WolfKKurtzAPfeiferMHöcherlKRieggerGAKrämerBK. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch2001; 442: 212–7.
22.
KyprianouNVaughanTBMichelMC. Apoptosis induction by doxazosin and other quinazoline alpha1-adrenoceptor antagonists: a new mechanism for cancer treatment?Naunyn Schmiedebergs Arch Pharmacol2009; 380: 473–7.
23.
DavisBRCutlerJAFurbergCDWrightJTFarberMAFelicettaJVStokesJD. ALLHAT Collaborative Research Group. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the antihypertensive and lipid-lowering treatment to prevent Heart Attack Trial. Ann Intern Med2002; 137: 313–20.
24.
González-JuanateyJRIglesiasMJAlcaideCPiñeiroRLagoF. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade. Circulation2003; 107: 127–31.
25.
HeinLSchmittJP. Alpha(1)-adrenoceptors in the heart – friend or foe?J Mol Cell Cardiol2003; 35: 1183–5. 4.
26.
GilesAR. Guidelines for the use of animals in biomedical research. Thromb Haemost1987; 58: 1078–84.
27.
TsoporisJNMarksAVan EldikLJO'HanlonDParkerTG. Regulation of the S100B gene by alpha 1-adrenergic stimulation in cardiac myocytes. Am J Physiol Heart Circ Physiol2003; 284: 193–203.
28.
TsoporisJNMarksAHaddadAO'HanlonDJollySParkerTG. S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes. Exp Cell Res2005; 303: 471–81.
29.
PerliniSPalladiniGFerreroITozziRFallariniSFacoettiANanoRClariFBuscaGFogariRFerrariAU. Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. Hypertension2005; 46: 1213–8.
30.
MonsalvePVeraOPérez AcuñaFMedinaOOstojichKLópezBTorresNLugo de FrancoVFonsecaR. Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension. Am Heart J1991; 121: 356–61.
31.
GarrisonJBKyprianouN. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Res2006; 66: 464–72.
32.
JooJHYoonSYKimJHPaikSGMinSRLimJSChoeISChoiIKimJW. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem2008; 103: 1183–97.
33.
SłomnickiŁPNawrotBLeśniakW. S100A6 binds p53 and affects its activity. Int J Biochem Cell Biol2008; 41: 784–90.
34.
SakataYYamamotoKMasuyamaTManoTNishikawaNKuzuyaTMiwaTHoriM. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure. J Hypertens2001; 19: 1905–12.
35.
ShimizuK. Effect of alpha 1- and alpha 2-adrenoceptor agonists and antagonists on ACTH secretion in intact and in hypothalamic deafferentated rats. Jpn J Pharmacol1984; 36: 23–33.
36.
FeldmanSWeidenfeldJ. Involvement of amygdalar alpha adrenoceptors in hypothalamo-pituitary-adrenocortical responses. Neuroreport1996; 7: 3055–7.
37.
HandleySLMithaniS. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol1984; 327: 1–5.
38.
YorimitsuMOkadaSYamaguchi-ShimaNShimizuTAraiJYokotaniK. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats. Life Sci2008; 82: 487–94.
39.
JagerLPde GraafGJWidjaja-GreefkesHC. Effects of alpha1-antagonists on production and release of aldosterone and other steroid hormones by porcine adrenocortical cells in vitro. Can J Physiol Pharmacol1998; 76: 676–83.
40.
MulateroPRabbiaFMilanAPaglieriCMorelloFChiandussiLVeglioF. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension2002; 40: 897–902.
41.
ElhawaryAMPangCC. Alpha 1b-adrenoceptors mediate renal tubular sodium and water reabsorption in the rat. Br J Pharmacol1994; 111: 819–24.
42.
OsbornJLHoldaasHThamesMDDiBonaGF. Renal adrenoceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog. Circ Res1983; 53: 298–305.
43.
HesseIFJohnsEJ. The role of alpha-adrenoceptors in the regulation of renal tubular sodium reabsorption and renin secretion in the rabbit. Br J Pharmacol1985; 84: 715–24.
44.
GrisantiLAPerezDMPorterJE. Modulation of immune cell function by α(1)-adrenergic receptor activation. Curr Top Membr2011; 67: 113–38.
45.
MazzeoRSDonovanDFleshnerMButterfieldGEZamudioSWolfelEEMooreLG. Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade. J Appl Physiol2001; 91: 2143–9.
46.
DelaflotteSAuguetMPirotzkyEClostreFBraquetP. Effects of atrial natriuretic factor (ANF) on phenylephrine-triggered intra- and extracellular calcium dependent contraction in rat aorta. J Auton Pharmacol1989; 9: 211–8.
47.
BilzerMPaumgartnerGGerbesAL. Prolonged antagonism of alpha 1-adrenergic vasoconstriction in the rat liver by atrial natriuretic peptide. Gastroenterology1995; 108: 803–11.
